NCT00014729View on ClinicalTrials.gov

Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

September 30, 2002

Conditions
Epidermolysis Bullosa
Interventions
DRUG

isotretinoin

All Listed Sponsors
lead

University of North Carolina

OTHER

NCT00014729 - Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa | Biotech Hunter | Biotech Hunter